StockData
Skinvisible, Inc. logo

Skinvisible, Inc. (SKVI) stock

SKVIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 0/30
$0.16+0.00 (+0.06%)

Close on Oct 19, 2026Market cap $843.54KP/E –Yield –

Skinvisible total assets

Total assets on the balance sheet at the end of each period.

Skinvisible's total assets was $123.33K at Jun 30, 2026. For fiscal 2025 it was $127.57K, down 19.4% from the year before. Over ten years it grew -10.8% a year on average. The highest annual figure on record is $874.05K in fiscal 2013.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$127.57K-19.4%
FY2024Dec 31, 2024$158.22K-2.9%
FY2023Dec 31, 2023$162.87K-34.0%
FY2022Dec 31, 2022$246.79K+8.6%
FY2021Dec 31, 2021$227.30K+13.5%
FY2020Dec 31, 2020$200.24K+10.2%
FY2019Dec 31, 2019$181.76K-17.5%
FY2018Dec 31, 2018$220.39K-65.1%
FY2017Dec 31, 2017$632.19K+86.2%
FY2016Dec 31, 2016$339.60K-15.2%
FY2015Dec 31, 2015$400.53K-38.0%
FY2014Dec 31, 2014$646.05K-26.1%
FY2013Dec 31, 2013$874.05K+15.9%
FY2012Dec 31, 2012$754.25K+154.0%
FY2011Dec 31, 2011$296.92K+8.8%
FY2010Dec 31, 2010$273.01K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$123.33K-14.0%
Q1 FY2026Mar 31, 2026$119.42K-20.1%
Q4 FY2025Dec 31, 2025$127.57K-19.4%
Q3 FY2025Sep 30, 2025$133.62K-10.1%
Q2 FY2025Jun 30, 2025$143.38K-12.1%
Q1 FY2025Mar 31, 2025$149.55K-2.5%
Q4 FY2024Dec 31, 2024$158.22K-2.9%
Q3 FY2024Sep 30, 2024$148.64K-19.7%
Q2 FY2024Jun 30, 2024$163.06K-16.9%
Q1 FY2024Mar 31, 2024$153.40K-25.5%
Q4 FY2023Dec 31, 2023$162.87K-34.0%
Q3 FY2023Sep 30, 2023$185.06K-33.7%
Q2 FY2023Jun 30, 2023$196.32K-38.8%
Q1 FY2023Mar 31, 2023$205.86K-9.4%
Q4 FY2022Dec 31, 2022$246.79K+14.4%
Q3 FY2022Sep 30, 2022$279.16K+21.0%
Q2 FY2022Jun 30, 2022$320.59K+90.0%
Q4 FY2021Dec 31, 2021$227.30K+13.5%
Q3 FY2021Sep 30, 2021$215.77K+17.2%
Q2 FY2021Jun 30, 2021$230.80K+6.6%
Q1 FY2021Mar 31, 2021$168.75K-3.4%
Q4 FY2020Dec 31, 2020$200.24K+10.2%
Q3 FY2020Sep 30, 2020$184.10K-11.5%
Q2 FY2020Jun 30, 2020$216.57K+2.6%
Q1 FY2020Mar 31, 2020$174.77K-14.5%
Q4 FY2019Dec 31, 2019$181.76K-17.5%
Q3 FY2019Sep 30, 2019$208.08K-8.8%
Q2 FY2019Jun 30, 2019$211.15K-46.6%
Q1 FY2019Mar 31, 2019$204.45K-52.0%
Q4 FY2018Dec 31, 2018$220.39K-65.1%
Q3 FY2018Sep 30, 2018$228.08K-61.4%
Q2 FY2018Jun 30, 2018$395.35K-25.5%
Q1 FY2018Mar 31, 2018$426.03K+32.4%
Q4 FY2017Dec 31, 2017$632.19K+86.2%
Q3 FY2017Sep 30, 2017$590.42K+68.4%
Q2 FY2017Jun 30, 2017$530.54K+43.1%
Q1 FY2017Mar 31, 2017$321.83K–
Q4 FY2016Dec 31, 2016$339.60K–
Q3 FY2016Sep 30, 2016$350.70K–
Q2 FY2016Jun 30, 2016$370.63K–

More Skinvisible figures

See a number that looks wrong?